Insider Selling: Tenet Healthcare (NYSE:THC) Director Sells $983,943.76 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $174.83 on Monday. The stock has a fifty day moving average price of $189.94 and a 200 day moving average price of $201.92. The stock has a market cap of $15.06 billion, a PE ratio of 9.09, a P/E/G ratio of 1.15 and a beta of 1.28. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.Tenet Healthcare’s revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts forecast that Tenet Healthcare Corporation will post 17.67 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors have recently added to or reduced their stakes in the company. Triumph Capital Management purchased a new stake in Tenet Healthcare during the third quarter valued at about $25,000. Activest Wealth Management purchased a new stake in Tenet Healthcare during the fourth quarter valued at about $26,000. Elyxium Wealth LLC purchased a new stake in Tenet Healthcare during the fourth quarter valued at about $29,000. Westside Investment Management Inc. grew its position in Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the period. Finally, Meeder Asset Management Inc. grew its position in Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on THC shares. Wells Fargo & Company dropped their price target on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Guggenheim dropped their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Royal Bank Of Canada dropped their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Wall Street Zen downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 11th. Finally, Robert W. Baird dropped their price target on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $244.16.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.